Targeting C3d in Combination with Daratumumab: a Strategy to Enhance Therapeutic Potential in Multiple Myeloma

被引：0
|
作者：
Baskar, Sivasubramanian [1 ]
Peng, Haiyong [2 ]
Rader, Christoph [2 ]
Wiestner, Adrian [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA
[2] Univ Florida, UF Scripps Biomed Res, Dept Immunol & Microbiol, Jupiter, FL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166681
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
651
引用
收藏
页码：9989 / 9990
页数：2
相关论文
共 50 条
  • [1] Targeting iron homeostasis in combination with IMiDs as a therapeutic strategy in multiple myeloma
    Ovejero, Sara
    Devin, Julie
    Caneque, Tatiana
    Henry, Laura
    Alibert, Laura
    Requirand, Guilhem
    Robert, Nicolas
    Steer, Alizee
    Machura, Amelie
    Hirtz, Christophe
    Bruyer, Angelique
    Vincent, Laure
    Cartron, Guillaume
    Herbaux, Charles
    Rodriguez, Raphael
    Bret, Caroline
    Moreaux, Jerome
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S149 - S149
  • [2] Targeting MET transcription as a therapeutic strategy in multiple myeloma
    Phillip, Cornel J.
    Stellrecht, Christine M.
    Nimmanapalli, Ramadevi
    Gandhi, Varsha
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 587 - 597
  • [3] Targeting MET transcription as a therapeutic strategy in multiple myeloma
    Cornel J. Phillip
    Christine M. Stellrecht
    Ramadevi Nimmanapalli
    Varsha Gandhi
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 587 - 597
  • [4] Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma
    Ovejero-Merino, Sara
    Devin, Julie
    Caneque, Tatiana
    Alibert, Laura
    Requirand, Guilhem
    Robert, Nicolas
    Steer, Alizee
    Machura, Amelie
    Hirtz, Christophe
    Bruyer, Angelique
    Vincent, Laure
    Cartron, Guillaume
    Herbaux, Charles
    Rodriguez, Raphael
    Bret, Caroline
    Moreaux, Jerome
    BLOOD, 2022, 140 : 9980 - 9981
  • [5] Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
    Neri, Paola
    Bahlis, Nizar J.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (07) : 776 - 796
  • [6] The therapeutic potential of cell cycle targeting in multiple myeloma
    Maes, Anke
    Menu, Eline
    De Veirman, Kim
    Maes, Ken
    Vanderkerken, Karin
    De Bruyne, Elke
    ONCOTARGET, 2017, 8 (52) : 90501 - 90520
  • [7] Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma
    Zhang, Yibo
    Chen, Lichao
    Wang, Yufeng
    Li, Xinxin
    Hughes, Tiffany
    Klingemann, Hans
    Benson, Don M.
    Yu, Jianhua
    BLOOD, 2016, 128 (22)
  • [8] Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma
    Jian Ma
    Shuiliang Wang
    Ming Zhao
    Xin-Sheng Deng
    Choon-Kee Lee
    Xiao-Dan Yu
    Bolin Liu
    BMC Cancer, 11
  • [9] Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma
    Ma, Jian
    Wang, Shuiliang
    Zhao, Ming
    Deng, Xin-Sheng
    Lee, Choon-Kee
    Yu, Xiao-Dan
    Liu, Bolin
    BMC CANCER, 2011, 11
  • [10] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
    Muz, Barbara
    Kusdono, Hubert D.
    King, Justin
    Kohnen, Daniel
    Fiala, Mark A.
    Vij, Ravi
    Capoccia, Ben
    Manning, Pamela T.
    Salama, Noha Nabil
    Azab, Abdel Kareem
    BLOOD, 2017, 130
12345